← Back to Research Radar
Academic Publication Academic Publication

The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide

898
Citations
April 1, 2025
Published Date

Research Abstract & Technology Focus

AbstractThe data sources and methods used to develop global cancer incidence and mortality statistics—the GLOBOCAN estimates—for the year 2022 are documented in this article, alongside a brief overview of the global cancer burden. The estimates, made available in 185 countries or territories worldwide for 36 cancer sites by sex and age, are based on the best available local data sources, namely population‐based cancer registries (for incidence) and national vital statistics (for mortality). In males, lung cancer was the most commonly diagnosed cancer worldwide in 2022 (1.57 million new cases [95% UI: 1.56–1.58]), followed by prostate cancer (1.47 million [1.46–1.48]). With 2.30 million (2.28–2.30) new cases estimated in 2022, breast cancer was the most diagnosed cancer in females, followed by lung cancer (0.91 million [0.90–0.91 million]) and cervical cancer (0.66 million [0.66–0.67]). The most common causes of cancer death in males and females were lung cancer (1.23 million [1.22–1.24]) and breast cancer (0.67 million [0.66–0.67]), respectively.
globocan cancer estimates sources methods snapshot
Read Full Literature

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

crossref.org › academic paper
100%
🔥

The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide

AbstractThe data sources and methods used to develop global cancer incidence and mortality statistics—the GLOBOCAN estimates—for the year 2022 are documented in this article, alongside a brief over...
crossref.org › academic paper
0%

Global burden of cardiovascular diseases: projections from 2025 to 2050

Abstract Aims The prediction of future trends in cardiovascular disease (CVD) mortality and their risk factors can assist policy-makers in health...
crossref.org › academic paper
0%

Global Carbon Budget 2024

Abstract. Accurate assessment of anthropogenic carbon dioxide (CO2) emissions and their redistribution among the atmosphere, ocean, and terrestrial biosphere in a changing climate is critical to be...
crossref.org › academic paper
0%

A foundation model for clinical-grade computational pathology and rare cancers detection

AbstractThe analysis of histopathology images with artificial intelligence aims to enable clinical decision support systems and precision medicine. The success of such applications depends on the a...
openalex.org › research concept
0%

Analysis of cell-free DNA for cancer diagnostics using liquid biopsies

Chromatin organisation influences gene regulation and genome stability, yet its dysregulation in cancer remains incompletely understood. This has become particularly important for patient diagnosti...

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide'?

This literature focuses on: AbstractThe data sources and methods used to develop global cancer incidence and mortality statistics—the GLOBOCAN estimates—for the year 2022 are documented in this article, alongside a brief overview of the global cancer burden. The estimates, m...

Which startups are commercializing the technology behind The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide?

Products like CostLogic are bringing this to market. Their focus is: AI-powered construction takeoffs, estimates, and invoices.

What other academic literature is closely related to 'The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide'?

Yes, highly correlated activity was mapped. An entry titled 'The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide' discusses this: AbstractThe data sources and methods used to develop global cancer incidence and mortality statistics—the GLOBOCAN estimates—for the year 2022 are ...

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.

Commercial Realization

Startups and Open Source tools heavily associated with the concepts explored in this paper.

  • Product Hunt
    CostLogic
    AI-powered construction takeoffs, estimates, and invoices

Associated Media Narrative